Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: Evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations

Vaccine

Volumn 21, Issue 1-2, 2002, Pages 98-107

  Konishi, Eiji ^a   Suzuki, Tomoyuki ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Inactivated vaccine; Japanese encephalitis; Subclinical infection

Indexed keywords

ANTIBODY; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; NS1 ANTIBODY; UNCLASSIFIED DRUG; NS1 PROTEIN, FLAVIVIRUS; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EPIDEMIC ENCEPHALITIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION RATE; JAPANESE ENCEPHALITIS VIRUS; MALE; PRIORITY JOURNAL; SERUM; URBAN AREA; VACCINATION; VIRUS INFECTION; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CHEMISTRY; CHO CELL; EPIDEMIOLOGY; HAMSTER; IMMUNOLOGY; SERODIAGNOSIS; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CHO CELLS; CRICETINAE; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS; JAPANESE ENCEPHALITIS VACCINES; NEUTRALIZATION TESTS; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 0037159617     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00433-4     Document Type: Article

References (37)

1. Shope RE. Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals. In: Schlesinger RW, editor. The togaviruses, New York: Academic Press; 1980. p. 47-82.
2. Burke DS, Monath TP. Flavivirus. In: Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia: Williams & Willkins; 2001. p. 1043-125.
3. Tsai TF, Yu YX. Japanese encephalitis vaccines. In: Plotkin SA, Mortimer Jr EA, editors. Vaccines. 2nd ed. Philadelphia: WB Saunders; 1994. p. 671-713.
4. Igarashi A. Japanese encephalitis: Virus, infection, and control. In: Kurstak E, editor. Control of virus diseases. 2nd ed. New York: Marcel Dekker; 1992. p. 309-42.
5. Kitano T, Oya A. Japanese encephalitis vaccine. In: Researcher's Associates National Institute of Health, editor, Vaccine handbook, Tokyo: Maruzen; 1996. p. 103-13.
6. Hsu T.C., Chow L.P., Wei H.Y., Chen C.L., Hsu S.T. A controlled field trial for an evaluation of effectiveness of mouse-brain Japanese encephalitis vaccine. J. Formosa Med. Assoc. 70:1971;55-62.
7. Hoke C.H., Nisalak A., Sangawhipa N. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 319:1988;608-614.
8. Lindenbach BD, Rice CM. Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia: Williams & Willkins; 2001. p. 991-1041.
9. Mason P.W. Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells. Virology. 169:1989;354-364.
10. Konishi E., Pincus S., Fonseca B.A.L., Shope R.E., Paoletti E., Mason P.W. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology. 185:1991;401-410.
11. Lin Y.L., Chen L.K., Liao C.L.et al. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J. Virol. 72:1998;191-200.
12. Schlesinger J.J., Brandriss M.W., Cropp C.B., Monath T.P. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J. Virol. 60:1986;1153-1155.
13. Schlesinger J.J., Brandriss M.W., Walsh E.E. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J. Gen. Virol. 68:1987;853-857.
14. Konishi E., Kurane I., Mason P.W., Innis B.L., Ennis F.A. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am. J. Trop. Med. Hyg. 53:1995;278-283.
15. Shu P.Y., Chen L.K., Chang S.F.et al. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination. Vaccine. 19:2001;1753-1763.
16. Takasaki T. Japanese encephalitis. In: Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health Labour and Welfare, Government of Japan, Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan, editors. Annual report 1999, National epidemiological surveillance of vaccine preventable diseases. 2001. p. 99-111 [in Japanese].
17. Konishi E., Mason P.W., Shope R.E. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis. J. Med. Virol. 48:1996;76-79.
18. Defraites R.F., Gambel J.M., Hoke C.H.et al. Japanese encephalitis vaccine (inactivated, BIKEN) in US soldiers: immunogenicity and safety of vaccine administered in two dosing regimens. Am J. Trop. Med. Hyg. 61:1999;288-293.
19. Takahashi J., Konishi E., Matsumura T. A survey of antibody to Toxoplasma gondii among patients of a hospital in Hyogo Prefecture, Japan, by enzyme-linked immunosorbent assay. Jpn. J. Parasitol. 34:1985;87-92.
20. Khin-Sane-Win, Matsumura T, Kumagai S, Uga S, Konishi E. Prevalence of antibody to Toxoplasma gondii in Hyogo Prefecture, Japan: comparison at a 10-year interval. Kobe J Med Sci 1997;43:159-68.
21. Konishi E., Takahashi J. Some epidemiological aspects of Toxoplasma infections in a population of farmers in Japan. Int. J. Epidemiol. 16:1987;277-281.
22. Konishi E. Culex tritaeniorhynchus and Aedes albopictus (Diptera: Culicidae) as natural vectors of Dirofilaria immitis (Spirurida: Filariidae) in Miki City, Japan. J. Med. Entomol. 26:1989;294-300.
23. Konishi E. Annual change in immunoglobulin G and M antibody levels to Toxoplasma gondii in human sera. Microbiol. Immunol. 33:1989;403-411.
24. Kitaoka M. Shift of age distribution of cases of Japanese encephalitis in Japan during the period 1950 to 1967. In: Hammon WM, Kitaoka M, Downs WG, editors. Immunization for Japanese encephalitis. Tokyo: Igaku Shoin; 1971. p. 287-91.
25. Kitano T. Effect and vaccination rates of Japanese encephalitis vaccine. Shounika Shinryou. 56:1993;2165-2170. [In Japanese].
26. Kanamitsu M., Hashimoto N., Urasawa S., Katsurada M., Kimura H. A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease. Biken J. 13:1970;313-328.
27. Rao Bhau L.N., Singh G., Gowal D.et al. Safety and efficacy of Japanese encephalitis vaccine produced in India. Indian J. Med. Res. 88:1988;301-307.
28. Gambel J.M., Defraites R., Hoke C.et al. Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series. J. Infect Dis. 171:1995;1074.
29. McAda P.C., Mason P.W., Schmaljohn C.S., Dalrymple J.M., Mason T.L., Fournier M.J. Partial nucleotide sequence of the Japanese encephalitis virus genome. Virology. 158:1987;348-360.
30. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 44:1986;283-292.
31. Konishi E., Fujii A., Mason P.W. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J. Virol. 75:2001;2204-2212.
32. Konishi E, Yamaoka M, Khin-Sane-Win, Kurane I, Takada K, Mason PW. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J Virol 1999;73:5527-34.
33. Garcia-Garcia J., Takashima I., Kariwa H., Hashimoto N. Improved sensitivity in the antibody-forming cell assay for Japanese encephalitis virus in mice by optimal fixation of cells and avidin-biotin complex (ABC) immunocytochemistry. J. Immunol. Methods. 157:1993;259-267.
34. Yabe S, Matsunaga Y. Japanese encephalitis. In: Infectious Diseases Control Division, Ministry of Health and Welfare, Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan, editors. Annual report 1996, National epidemiological surveillance of vaccine preventable diseases. 1998. p. 50-80 [in Japanese].
35. Matsunaga Y., Yabe S., Taniguchi K., Nakayama M., Kurane I. Current status of Japanese encephalitis in Japan. J. Jpn. Assoc. Inf. Dis. 73:1999;97-103.
36. Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare. Population table. In: Vital statistics of Japan 1985. vol. 1. 1986. p. 382-95.
37. Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare. Population table. In: Vital statistics of Japan 1991. vol. 1. 1992. p. 406-17.